Evidence map›Paper›PMID 37400627›Full record

ArticleCommunications biology2023

Mitochondrial DNA is a target of HBV integration.

Domenico Giosa, Daniele Lombardo, Cristina Musolino, Valeria Chines, Giuseppina Raffa, Francesca Casuscelli di Tocco, Deborah D'Aliberti, Giuseppe Caminiti, Carlo Saitta, Angela Alibrandi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Domenico Giosa *Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Daniele Lombardo *Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Cristina MusolinoLaboratory of Molecular Hepatology, University Hospital of Messina, Messina, Italy.
Valeria ChinesDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Giuseppina RaffaDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Francesca Casuscelli di ToccoDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Deborah D'AlibertiDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Giuseppe CaminitiLaboratory of Molecular Hepatology, University Hospital of Messina, Messina, Italy.
Carlo SaittaDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Angela AlibrandiDepartment of Economics, University of Messina, Messina, Italy.
Riccardo Aiese CiglianoSequentia Biotech Sl, Barcelona, Spain.
Orazio RomeoDepartment of ChiBioFarAm, University of Messina, Messina, Italy.
Giuseppe NavarraDepartment of Human Pathology, University Hospital of Messina, Messina, Italy.
Giovanni RaimondoDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Teresa PollicinoDepartment of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy. tpollicino@unime.it.ORCID 0000-0001-6602-3035
University of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) may integrate into the genome of infected cells and contribute to hepatocarcinogenesis. However, the role of HBV integration in hepatocellular carcinoma (HCC) development remains unclear. In this study, we apply a high-throughput HBV integration sequencing approach that allows sensitive identification of HBV integration sites and enumeration of integration clones. We identify 3339 HBV integration sites in paired tumour and non-tumour tissue samples from 7 patients with HCC. We detect 2107 clonally expanded integrations (1817 in tumour and 290 in non-tumour tissues), and a significant enrichment of clonal HBV integrations in mitochondrial DNA (mtDNA) preferentially occurring in the oxidative phosphorylation genes (OXPHOS) and D-loop region. We also find that HBV RNA sequences are imported into the mitochondria of hepatoma cells with the involvement of polynucleotide phosphorylase (PNPASE), and that HBV RNA might have a role in the process of HBV integration into mtDNA. Our results suggest a potential mechanism by which HBV integration may contribute to HCC development.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsDNA, MitochondrialHepatitis B virusHumansMitochondriaVirus IntegrationDNA, Mitochondrial

Identifiers

PMID37400627
PMCPMC10318008
OpenAlexW4382987232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.